The goal is to try to contain the current fifth wave of the pandemic.
The French High Authority for Health (HAS) recommended this Friday that the third dose of the coronavirus vaccine be supplied three months after receiving the second.
In addition, the HAS also recommended administering a third dose to adolescents 12 to 17 years old who have immunodeficiency or risk diseases, according to a statement.
The objective of these recommendations is to try to contain the current fifth wave of the pandemic, which, driven by the omicron variant, has brought the level of infections in France to successive records: 91,068 on Thursday, from 48,473 on Monday.
The body justifies inoculating the third dose at three months in which published studies show that the vaccines maintain a high level of protection against the omicron variant with the new inoculation.
The data “show a jump in vaccine efficacy to 75% two weeks after a booster dose,” states the HAS.
These recommendations must now be ratified by the Government, which during the pandemic is following the advice of the body.
The French authorities had already advanced the third dose in succession. The first period after the second dose was six months, which later went to five and later to the current four.
Israel bets on the fourth dose of the vaccine against COVID-19 to face the omicron variant
Chile will begin to apply fourth dose of the vaccine against COVID-19 in mid-February
Some 22 million people have already received the third dose of the vaccine, representing almost a third of the population, which totals 67 million.
The HAS will rule later on the advisability of vaccinating all adolescents between 12 and 17 years of age. (I)
Paul is a talented author and journalist with a passion for entertainment and general news. He currently works as a writer at the 247 News Agency, where he has established herself as a respected voice in the industry.
